Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Aug 21;91(8):373-374. doi: 10.1212/WNL.0000000000006042. No abstract available.

PMID:
30126885
2.

Identifying priority outcomes that influence selection of disease-modifying therapies in MS.

Day GS, Rae-Grant A, Armstrong MJ, Pringsheim T, Cofield SS, Marrie RA.

Neurol Clin Pract. 2018 Jun;8(3):179-185. doi: 10.1212/CPJ.0000000000000449.

PMID:
30105155
3.

Electroclinical features of seizures associated with autoimmune encephalitis.

Steriade C, Moosa ANV, Hantus S, Prayson RA, Alexopoulos A, Rae-Grant A.

Seizure. 2018 Aug;60:198-204. doi: 10.1016/j.seizure.2018.06.021. Epub 2018 Jun 28.

PMID:
30031297
4.

Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution.

Di Lorenzo R, Mente K, Li J, Shayya L, Rae-Grant A, Li Y, Jammoul A.

J Neurol. 2018 Jul 9. doi: 10.1007/s00415-018-8959-8. [Epub ahead of print]

PMID:
29987589
5.

Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease.

Uchida A, Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Leverenz JB, Srivastava SK, Ehlers JP.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2768-2777. doi: 10.1167/iovs.17-23240.

6.

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345.

PMID:
29686117
7.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347.

PMID:
29686116
8.

Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis.

Steriade C, Hantus S, Moosa ANV, Rae-Grant AD.

Clin Neurophysiol. 2018 Oct;129(10):2197-2204. doi: 10.1016/j.clinph.2018.02.130. Epub 2018 Mar 10.

PMID:
29580710
9.

Transient neurologic syndromes: A diagnostic approach.

Abbatemarco JR, Rae-Grant AD.

Cleve Clin J Med. 2018 Feb;85(2):155-163. doi: 10.3949/ccjm.85a.17022. Review.

10.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

PMID:
29282327
11.

Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.

Haselkorn JK, Hughes C, Rae-Grant A, Jung Henson L, Bever CT, Lo AC, Brown TR, Kraft GH, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurol Clin Pract. 2017 Jun;7(3):189-190. doi: 10.1212/01.CPJ.0000520916.56328.f5. No abstract available.

12.

Outcomes of Bariatric Surgery in Morbidly Obese Patients with Multiple Sclerosis.

Bencsath K, Jammoul A, Aminian A, Shimizu H, Fisher CJ, Schauer PR, Rae-Grant A, Brethauer SA.

J Obes. 2017;2017:1935204. doi: 10.1155/2017/1935204. Epub 2017 Feb 19.

13.

Antidepressant Drug Treatment in Association with Multiple Sclerosis Disease-Modifying Therapy: Using Explorys in the MS Population.

Mirsky MM, Marrie RA, Rae-Grant A.

Int J MS Care. 2016 Nov-Dec;18(6):305-310. doi: 10.7224/1537-2073.2016-056.

14.

Clinical utility of seropositive voltage-gated potassium channel-complex antibody.

Jammoul A, Shayya L, Mente K, Li J, Rae-Grant A, Li Y.

Neurol Clin Pract. 2016 Oct;6(5):409-418.

15.

Author Response.

Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. No abstract available.

PMID:
27500299
16.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

McDonnell GV, Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. doi: 10.1212/WNL.0000000000002578. No abstract available.

PMID:
27044615
17.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

18.

Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.

Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Ehlers JP, Leverenz JB.

Am J Alzheimers Dis Other Demen. 2016 Aug;31(5):430-6. doi: 10.1177/1533317515628053. Epub 2016 Feb 16.

PMID:
26888864
19.

Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.

Jammoul A, Li Y, Rae-Grant A.

Cleve Clin J Med. 2016 Jan;83(1):43-53. doi: 10.3949/ccjm.83a.14112. Review.

20.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Haselkorn JK, Hughes C, Rae-Grant A, Henson LJ, Bever CT, Lo AC, Brown TR, Kraft GH, Getchius T, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurology. 2015 Nov 24;85(21):1896-903. doi: 10.1212/WNL.0000000000002146. Review.

21.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Rae-Grant A, Bennett A, Sanders AE, Phipps M, Cheng E, Bever C.

Neurology. 2015 Nov 24;85(21):1904-8. doi: 10.1212/WNL.0000000000001965. Epub 2015 Sep 2. Review. No abstract available. Erratum in: Neurology. 2016 Apr 12;86(15):1465.

22.

No Association of Chronic Cerebrospinal Venous Insufficiency with Multiple Sclerosis.

Fox RJ, Diaconu C, Baus L, Grattan A, Katzan I, Lee JC, Raber L, Rae-Grant A, Ramesh S, Lu M, Kim ESh.

Can J Neurol Sci. 2016 Jan;43(1):195-7. doi: 10.1017/cjn.2015.245. Epub 2015 Jul 21. No abstract available.

PMID:
26194114
23.

Chronic cerebrospinal venous insufficiency: pitfalls and perils of sonographic assessment.

Kim ES, Diaconu C, Baus L, Fox RJ, Grattan A, Katzan I, Raber L, Rae-Grant A, Lu M.

J Ultrasound Med. 2015 Jun;34(6):1097-106. doi: 10.7863/ultra.34.6.1097.

PMID:
26014330
24.

Observations on the brain vasculature in multiple sclerosis: A historical perspective.

Rae-Grant AD, Wong C, Bernatowicz R, Fox RJ.

Mult Scler Relat Disord. 2014 Mar;3(2):156-62. doi: 10.1016/j.msard.2013.08.005. Epub 2013 Dec 19. Review.

PMID:
25878003
25.

Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center.

Li Y, Jammoul A, Mente K, Li J, Shields RW, Vernino S, Rae-Grant A.

Muscle Nerve. 2015 Sep;52(3):386-91. doi: 10.1002/mus.24559. Epub 2015 Jun 30.

PMID:
25557122
26.

A systematic review of stress-management interventions for multiple sclerosis patients.

Reynard AK, Sullivan AB, Rae-Grant A.

Int J MS Care. 2014 Fall;16(3):140-4. doi: 10.7224/1537-2073.2013-034.

27.

Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.

Diaconu CI, Fox RJ, Grattan A, Rae-Grant A, Lu M, Gornik HL, Kim ES.

Neurol Clin Pract. 2013 Oct;3(5):386-391.

28.

Unusual symptoms and syndromes in multiple sclerosis.

Rae-Grant AD.

Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):992-1006. doi: 10.1212/01.CON.0000433287.30715.07. Review.

PMID:
23917097
29.

Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Li HF, Gao X, Hong Y, Patwa HS, Chaudhry V, Rae-Grant AD, So YT, Alto P.

Neurology. 2012 Sep 25;79(13):1411; author reply 1411. No abstract available.

30.

A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.

Diaconu CI, Staugaitis SM, Fox RJ, Rae-Grant A, Schwanger C, McBride JM.

Neurol Res. 2012 Oct;34(8):810-8. doi: 10.1179/1743132812Y.0000000071.

31.

Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.

Hersh C, Rae-Grant A.

Ther Adv Neurol Disord. 2012 Jul;5(4):199-204. doi: 10.1177/1756285612447091.

32.

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT.

Neurology. 2012 Mar 27;78(13):1009-15. doi: 10.1212/WNL.0b013e31824de293. Review.

PMID:
22454268
33.

Chronic cerebrospinal venous insufficiency as a cause of multiple sclerosis: controversy and reality.

Diaconu CI, Conway D, Fox RJ, Rae-Grant A.

Curr Treat Options Cardiovasc Med. 2012 Apr;14(2):203-14. doi: 10.1007/s11936-012-0168-7.

PMID:
22311713
34.

Self-management in neurological disorders: systematic review of the literature and potential interventions in multiple sclerosis care.

Rae-Grant AD, Turner AP, Sloan A, Miller D, Hunziker J, Haselkorn JK.

J Rehabil Res Dev. 2011;48(9):1087-100. Review.

35.

Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?

Fox RJ, Rae-Grant A.

Neurology. 2011 Jul 12;77(2):98-100. doi: 10.1212/WNL.0b013e318212a915. Epub 2011 Apr 13. No abstract available.

PMID:
21490321
36.

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A.

Neurology. 2011 Jan 18;76(3):294-300. doi: 10.1212/WNL.0b013e318207b1f6. Review.

37.

Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.

Bermel RA, Rae-Grant AD, Fox RJ.

Mult Scler. 2010 Nov;16(11):1335-40. doi: 10.1177/1352458510377334. Epub 2010 Jul 29.

PMID:
20670982
38.

Management of acute exacerbations in multiple sclerosis.

Ontaneda D, Rae-Grant AD.

Ann Indian Acad Neurol. 2009 Oct;12(4):264-72. doi: 10.4103/0972-2327.58283.

39.

Advances in the immune pathogenesis and treatment of multiple sclerosis.

Huang D, Rae-Grant A.

Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):20-31.

PMID:
20021335
40.

Neurodegeneration and neuroprotective agents in multiple sclerosis.

Fong JS, Rae-Grant A, Huang D.

Recent Pat CNS Drug Discov. 2008 Nov;3(3):153-65. Review.

PMID:
18991805
41.

Diagnosis and neuroimaging of acute stroke producing distal arm monoparesis.

Castaldo J, Rodgers J, Rae-Grant A, Barbour P, Jenny D.

J Stroke Cerebrovasc Dis. 2003 Nov-Dec;12(6):253-8.

PMID:
17903936
42.

Pure monoparesis: what makes it different.

Isayev Y, Castaldo J, Rae-Grant A, Barbour P.

Arch Neurol. 2006 May;63(5):786; author reply 786. No abstract available.

PMID:
16682556
43.

The vibration quantitation scale (VQS): a simple, reproducible bedside measure of sensory function in multiple sclerosis.

Carter J, Wasser T, Statler S, Rae-Grant AD.

Can J Neurol Sci. 2004 Nov;31(4):490-3.

PMID:
15595253
44.

Welcome 2000: concern for the patient, collaboration with colleagues, and confidence for the future.

Rae-Grant Q, Rae-Grant AD.

Can J Psychiatry. 2000 Feb;45(1):28-9. No abstract available.

PMID:
10696486
45.

Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity.

Rae-Grant AD, Eckert NJ, Bartz S, Reed JF.

Mult Scler. 1999 Jun;5(3):179-83.

PMID:
10408718
46.

A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma.

Forman D, Rae-Grant AD, Matchett SC, Cowen JS.

Chest. 1999 Mar;115(3):899-901.

PMID:
10084515
47.

Outcome of severe brain injury: a multimodality neurophysiologic study.

Rae-Grant AD, Eckert N, Barbour PJ, Castaldo JE, Gee W, Wohlberg CJ, Lin ZS, Reed JF 3rd.

J Trauma. 1996 Mar;40(3):40l-7.

PMID:
8601857
48.

Differentiation of alpha coma from awake alpha by nonlinear dynamics of electroencephalography.

Kim YW, Krieble KK, Kim CB, Reed J, Rae-Grant AD.

Electroencephalogr Clin Neurophysiol. 1996 Jan;98(1):35-41.

PMID:
8689992
49.

Internal carotid artery redundancy is significantly associated with dissection.

Barbour PJ, Castaldo JE, Rae-Grant AD, Gee W, Reed JF 3rd, Jenny D, Longennecker J.

Stroke. 1994 Jun;25(6):1201-6.

PMID:
8202980
50.

Primary angiitis of the central nervous system: unusual MR appearance.

Shoemaker EI, Lin ZS, Rae-Grant AD, Little B.

AJNR Am J Neuroradiol. 1994 Feb;15(2):331-4.

PMID:
8192081

Supplemental Content

Loading ...
Support Center